Codexis, Inc.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing;
Biotechnology
US, Redwood City [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Codexis, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | -0.5000 | -0.185 | 35 | 41 | -19 | -12 | -12 | -13 | -19 | -16 | 21 | 20 |
| 2016 | -0.1900 | -0.180 | 41 | 48 | -7 | -12 | -2 | -15 | -7 | -19 | 22 | 23 |
| 2017 | -0.2100 | -0.347 | 48 | 51 | -8 | -23 | -4 | -16 | -8 | -20 | 25 | 25 |
| 2018 | -0.5000 | -0.125 | 50 | 61 | -22 | -13 | -21 | -12 | -22 | -14 | 29 | -1 |
| 2019 | -0.2100 | -0.113 | 60 | 71 | -10 | -7 | -10 | -22 | -11 | -28 | 29 | 35 |
| 2020 | -0.2100 | -0.347 | 68 | 68 | -11 | -28 | -7 | -22 | -12 | -28 | 31 | 5 |
| 2021 | -0.4000 | -0.384 | 69 | 103 | -24 | -26 | -19 | -16 | -23 | -28 | 35 | 76 |
| 2022 | -0.3300 | -0.548 | 104 | 137 | -21 | -25 | -16 | -14 | -22 | -28 | 49 | 91 |
| 2023 | -0.5100 | -1.149 | 138 | 63 | -33 | -76 | -23 | -16 | -31 | -31 | 52 | 32 |
| 2024 | -1.1200 | -0.794 | 70 | 65 | -76 | -54 | -49 | -18 | -68 | -23 | 53 | 33 |
| 2025 | - | -0.687 | - | 66 | - | -45 | - | -18 | - | -24 | - | 34 |
| 2026 | - | 2.F11X/td> | - | 2.F11X/td> | - | 2.F11X/td> | - | 2.F111/td> | - | 2.F111 | - | 2.F111 |
| 2027 | - | 1.F12X/td> | - | 1.F12X/td> | - | 1.F12X/td> | - | 1.F121/td> | - | 1.F121 | - | 1.F121 |
| 2028 | - | 0.F13X/td> | - | 0.F13X/td> | - | 0.F13X/td> | - | 0.F131/td> | - | 0.F131 | - | 0.F131 |